Clinical Trial Update: Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study

View source ↗

Summary

A completed SPS3 ancillary study that examined inflammatory marker levels in people with stroke as part of secondary prevention research.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Stroke

Snippet

Sponsor: Columbia University | Conditions: Hypertension, Stroke | Status: COMPLETED